Tirzepatide × Skye Peptides - Lab Test, March 2025

This independent lab test from Janoshik Labs confirms Tirzepatide 10mg from Skye Peptides at 99.732% purity. The analysis was conducted on March 7, 2025, with tested quantity of 10.90mg. Tirzepatide is a dual GIP/GLP-1 receptor agonist researched for its potential effects on metabolic regulation, weight management, and glycemic control. The high purity level of 99.732% indicates minimal contamination and high-grade synthesis quality. The tested quantity of 10.90mg aligns with the stated label claim of 10mg, demonstrating product consistency. The full certificate of analysis is available for verification on this page.